News for Immune Therapeutics, Inc. (IMUN)

News for Immune Therapeutics, Inc.
Date Headline
Sep 06, 2017 09:12 AM Immune Therapeutics, Inc. Announces Exclusive Agreement for Sale of Lodonal in Kenya Valued at Over $31 Million
Sep 06, 2017 08:05 AM Immune Therapeutics, Inc. Announces Exclusive Agreement For Sale Of Lodonal In Kenya Valued At Over $31 Million
Aug 23, 2017 09:04 AM Immune Therapeutics, Inc. Appoints John H. Abeles, M.D. as Chairman and CEO of Company’s Subsidiary, Cytocom, Inc. and as Senior Adviser to Immune Therapeutics, Inc.
Jun 05, 2017 08:45 AM Immune Therapeutics to Present at the 7th Annual LD Micro Invitational
Mar 08, 2017 12:50 PM Immune Therapeutics Signs Distribution MOU for Lodonal in Kenya; Company Plans to Open Kenya for Lodonal in 2017